FDA Approved: BETAPACE — Supplemental Application (Legacy Pharma USA, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for BETAPACE (sotalol hydrochloride) filed by Legacy Pharma USA, Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Atrial Flutter
• Ventricular Arrhythmias

Drugs mentioned

• Betapace (sotalol)

Snippet

SUPPL AP for BETAPACE (SOTALOL HYDROCHLORIDE)